Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer

British Journal of Radiology

Volumn 82, Issue 979, 2009, Pages 585-594

  Clark, C H ^a   Miles, E A ^a   Guerrero Urbano, M T ^a   Bhide, S A ^a   Bidmead, A M ^a   Harrington, K J ^a   Nutting, C M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LINEAR ACCELERATOR; MULTICENTER STUDY; PAROTID GLAND; QUALITY CONTROL; TREATMENT PLANNING;

HEAD AND NECK NEOPLASMS; HUMANS; PAROTID GLAND; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 67649808109     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/31966505     Document Type: Article

References (38)

1. Ship JA, Eisbruch A, D'Hondt E, Jones RE. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results. J Dent Res 1997;76:807-813 (Pubitemid 127732671)
2. D'Hondt E, Eisbruch A, Ship JA. The influence of preradiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. Spec Care Dent 1998;18:102-108 (Pubitemid 128711132)
3. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-587
4. Kuppersmith RB, Greco SC, Teh BS, Donovan DT, Grant W, Chiu JK, et al. Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck. Ear Nose Throat J 1999;78:238-251 (Pubitemid 29186422)
5. PARSPORT: A multi-centre randomized study of parotid sparing intensity modulated radiotherapy versus conventional radiotherapy in patients with head and neck cancer. ISRCTN: 48243537. Available from: http://pfsearch.ukcrn.org.uk/ StudyDetail.aspx?TopicID=1,StudyID=1283
6. Clark CH, Mubata CD, Meehan CA, Bidmead AM, Staffurth J, Humphreys ME, et al. IMRT clinical implementation: prostate and pelvic node irradiation by Helios using a 120-leaf MLC. J Appl Clin Med Phys 2002;3:273-284
7. Adams EJ, Convery DJ, Cosgrove VP, McNair HA, Staffurth JN, Vaarkamp J, et al. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol 2004;70:1-10. (Pubitemid 38177156)
8. James HV, Scrase CD, Poynter AJ. Practical experience with intensity-modulated radiotherapy. Br J Radiol 2004;77:3-14. (Pubitemid 38219927)
9. Budgell GJ, Perrin BA, Mott JH, Fairfoul J, Mackay RI. Quantitative analysis of patient-specific dosimetric IMRT verification. Phys Med Biol 2005;50:103-119 (Pubitemid 40185404)
10. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT. Med Phys 2003;30:2089-2115
11. Galvin JM, Ezzell G, Eisbruch A, Yu C, Butler B, Xiao Y, et al. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004;58:1616-1634 (Pubitemid 38438327)
12. Marcie S, Aletti P, Lefkopoulos D, Tomsej M. Quality assurance program for intensity-modulated radiotherapy (IMRT) treatments of head and neck carcinomas. Cancer Radiother 2003;7:172-178 (Pubitemid 36808161)
13. Zefkili S, Tomsej M, Aletti P, Bidault F, Bridier A, Marchesi V, et al. Recommendations for a head and neck IMRT quality assurance protocol. Cancer Radiother 2004;8:364-379 (Pubitemid 40023169)
14. Aird EG, Williams C, Mott GT, Dische S, Saunders MI. Quality assurance in the CHART clinical trial. Radiother Oncol 1995;36:235-244
15. Venables K, Winfield E, Deighton A, Aird E, Hoskin P. A survey of radiotherapy quality control practice in the United Kingdom for the START trial. Radiother Oncol 2001;60:311-318 (Pubitemid 32763120)
16. Winfield E, Deighton A, Venables K, Hoskin PJ, Aird EG. Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer. Clin Oncol 2002;14:267-271 (Pubitemid 34919254)
17. Mayles WP, Moore AR, Aird EG, Bidmead AM, Dearnaley DP, Griffiths SE, et al. Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397). Radiother Oncol 2004;73:199-207. (Pubitemid 39470160)
18. Clark CH, Chantler H, Edwards C, Nordmark Hansen V, James H, Webster G, et al. How well can UK centres deliver head and neck IMRT? A dosimetry audit for the PARSPORT trial ESTRO meeting Gothenburg. Radiother Oncol 2008;8882:S26.
19. Griffiths SE, Stanley S, Sydes M, RT01 Radiographers Group, on behalf of all the RT01 Collaborators. Recommendations on best practice for radiographer setup of conformal radiotherapy treatment for patients with prostate cancer: experience developed during the MRC RT01 trial (ISRTCN 47772397) J Radiother Pract 2004;4:107-117
20. Steenbakkers RJHM, Duppen JC, Fitton I, Deurloo KE, Zijp LJ, Comans EF, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: A "Big Brother" evaluation. Radiother Oncol 2005;77:182-190
21. Guerrero Urbano MT, Clark CH, Kong C, Miles EA, Dearnaley DP, Harrington KJ, et al. Target volume definition for head and neck IMRT: pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol 2007;19:604-613
22. Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003;69:227-236 (Pubitemid 37485996)
23. Wu Q, Manning, M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195-205. (Pubitemid 30021500)
24. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000;46:619-630 (Pubitemid 30100639)
25. Lillicrap SC, Owen B, Williams JR, Williams PC. The IPSM code of practice for high-energy photon therapy dosimetry based on the NPL absorbed dose calibration service. Phys Med Biol 1990;35:1355-1360 (Pubitemid 20304104)
26. Thwaites DI, Burns DT, Klevenhagen SC, Nahum AE, Pitchford WG. The IPEMB code of practice for electron dosimetry for radiotherapy beams of initial energy from 2 to 50 MeV based on an air kerma calibration. Phys Med Biol 1996;41:2557-2603 (Pubitemid 26412557)
27. Thwaites DI, DuSautoy AR, Jordan T, McEwan MR, Nisbet A, Nahum AE, et al The IPEM code of practice for electron dosimetry for radiotherapy beams of initial energy from 4 to 25 MeV based on an absorbed dose to water calibration IPEM Working Party. Phys Med Biol 2003;48:2929-2970 (Pubitemid 37192914)
28. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys 1998;25:656-661 (Pubitemid 28234885)
29. Gilbeau L, Octave-Prignot M, Loncol T, Renard L, Scalliet P, Gregoire V. Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumours. Radiother Oncol 2001;58:155-162 (Pubitemid 32146517)
30. Humphreys M, Guerrero Urbano MT, Mubata C, Miles EA, Harrington KJ, et al. Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging. Radiother Oncol 2005;77:39-44. (Pubitemid 41503387)
31. Das S, Cullip T, Tracton G, Chang S, Marks L, Anscher M, et al Beam orientation selection for intensity-modulated radiation therapy based on target equivalent uniform dose maximization. Int J Radiat Oncol Biol Phys 2003;55:215-224 (Pubitemid 36020362)
32. Bragg CM, Conway J, Robinson MH. The role of intensity-modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys 2002;52:729-738 (Pubitemid 34158736)
33. Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnalry DP, Robinson MH, et al Optimization of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal and intensity-modulated techniques. Radiother Oncol 2001;60:163-172 (Pubitemid 32601969)
34. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM. Intensity modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 2004;70:189-198 (Pubitemid 38353019)
35. Deng J, Pawlicki T, Chen Y, Li J, Jiang SB, Ma CM. The MLC tongue-and-groove effect on IMRT dose distributions. Phys Med Biol 2001;46:1039-1060 (Pubitemid 32366605)
36. Leif J, Roll D, Followill D, Ibbott G. The value of credentialing. Int J Radiat Oncol Biol Phys 2006;66:S716.
37. The National Radiotherapy Trials Quality Assurance Group (RTTQA). Available at: http://rttrialsqa.org.uk/
38. Miles EA, Clark CH, Guerrero Urbano MT, Bidmead AM, Dearnaley DP, Harrington KJ, et al. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol 2005;77:241-246 (Pubitemid 41785331)